DE69636058D1 - Gebundene vorstufen von arztneimitteln aufgrund kovalenter verknüpfung mit glutathionanalogen - Google Patents

Gebundene vorstufen von arztneimitteln aufgrund kovalenter verknüpfung mit glutathionanalogen

Info

Publication number
DE69636058D1
DE69636058D1 DE69636058T DE69636058T DE69636058D1 DE 69636058 D1 DE69636058 D1 DE 69636058D1 DE 69636058 T DE69636058 T DE 69636058T DE 69636058 T DE69636058 T DE 69636058T DE 69636058 D1 DE69636058 D1 DE 69636058D1
Authority
DE
Germany
Prior art keywords
glutathional
covalency
analogs
linking
products based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636058T
Other languages
English (en)
Other versions
DE69636058T2 (de
Inventor
H Lyttle
M Kauvar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telik Inc
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of DE69636058D1 publication Critical patent/DE69636058D1/de
Application granted granted Critical
Publication of DE69636058T2 publication Critical patent/DE69636058T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69636058T 1996-01-04 1996-12-20 Gebundene vorstufen von arztneimitteln aufgrund kovalenter verknüpfung mit glutathionanalogen Expired - Fee Related DE69636058T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/582,966 US5880097A (en) 1996-01-04 1996-01-04 Tethered prodrugs
US582966 1996-01-04
PCT/US1996/020042 WO1997025342A1 (en) 1996-01-04 1996-12-20 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione

Publications (2)

Publication Number Publication Date
DE69636058D1 true DE69636058D1 (de) 2006-05-24
DE69636058T2 DE69636058T2 (de) 2006-11-09

Family

ID=24331149

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636058T Expired - Fee Related DE69636058T2 (de) 1996-01-04 1996-12-20 Gebundene vorstufen von arztneimitteln aufgrund kovalenter verknüpfung mit glutathionanalogen

Country Status (10)

Country Link
US (1) US5880097A (de)
EP (1) EP0873355B1 (de)
JP (1) JP2000503648A (de)
AT (1) ATE323716T1 (de)
AU (1) AU1422897A (de)
DE (1) DE69636058T2 (de)
DK (1) DK0873355T3 (de)
ES (1) ES2258272T3 (de)
PT (1) PT873355E (de)
WO (1) WO1997025342A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119724A1 (en) * 1995-11-22 2003-06-26 Ts`O Paul O.P. Ligands to enhance cellular uptake of biomolecules
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
DK1045897T3 (da) 1998-01-23 2002-05-13 Newbiotics Inc Enzymatisk katalyserede, terapeutiske midler
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
WO2001007088A2 (en) 1999-07-22 2001-02-01 Newbiotics, Inc. Methods for treating therapy-resistant tumors
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0016447D0 (en) * 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
GB0017852D0 (en) * 2000-07-20 2000-09-06 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
IT1318696B1 (it) * 2000-09-15 2003-08-27 Pharmacia & Upjohn Spa Coniugati di glutatione con derivati della distamicina ad attivita'antitumorale.
GB0029004D0 (en) * 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
WO2002043771A2 (en) 2000-12-01 2002-06-06 Cell Works Inc. Conjugates of glycosylated/galactosylated peptide
US20070249651A1 (en) * 2001-06-20 2007-10-25 Nerviano Medical Sciences S.R.I. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
US7172905B2 (en) * 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
US6969592B2 (en) * 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
AU2003247907A1 (en) * 2002-07-05 2004-01-23 University Of Chicago Characterization of biochips containing self-assembled monolayers with maldi-tof-ms
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
TW200538149A (en) * 2004-05-20 2005-12-01 Telik Inc Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413635D0 (en) * 1984-05-29 1984-07-04 Lucas Ind Plc Liquid level indicators
JP2919867B2 (ja) * 1989-09-27 1999-07-19 千寿製薬株式会社 抗腫瘍剤
US5556942A (en) * 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
US5545621A (en) * 1991-04-29 1996-08-13 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems

Also Published As

Publication number Publication date
JP2000503648A (ja) 2000-03-28
WO1997025342A1 (en) 1997-07-17
US5880097A (en) 1999-03-09
ATE323716T1 (de) 2006-05-15
PT873355E (pt) 2006-07-31
EP0873355A1 (de) 1998-10-28
ES2258272T3 (es) 2006-08-16
EP0873355B1 (de) 2006-04-19
DK0873355T3 (da) 2006-08-21
AU1422897A (en) 1997-08-01
DE69636058T2 (de) 2006-11-09

Similar Documents

Publication Publication Date Title
DE69636058D1 (de) Gebundene vorstufen von arztneimitteln aufgrund kovalenter verknüpfung mit glutathionanalogen
FR2678615B1 (fr) Benzofuranne-2-ones thiomethylees, leur preparation et leur application comme stabilisants de matieres organiques.
ATE71287T1 (de) Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
DE3684220D1 (de) Zusammensetzung mit verzoegerter abgabe.
DE69432758D1 (en) Therapeutisch wirksame peptidderivate
ES2019280B3 (es) Montaje de jeringuillas.
DE3669315D1 (de) Phenoxyalkylaminopyrimidinderivate, deren herstellung und diese enthaltende insektizide und akarizide zusammensetzungen.
PT942901E (pt) Iminas ciclicas utilizadas como pesticidas
ATE205500T1 (de) Dimere artemisinin-verbindungen mit aktivität gegen krebs
FI970132A (fi) Injektioruisku
HN1998000088A (es) Tratamiento de resistencia a la insulina
DE3650631D1 (de) Lösungsmittelbeständige Polyzykloolefine
DE3877748T2 (de) Halterungsbefestigung fuer konstruktionsbalken.
EA199900580A1 (ru) Фармацевтические производные аминофосфоновой кислоты
ITBO950533A0 (it) Siringa per iniezioni ipodermiche.
EA199901024A1 (ru) Фармацевтическая антивирусная композиция, содержащая глицирризиновую кислоту и, по меньшей мере, один белок, обладающий антивирусной активностью
ATE45979T1 (de) Stabilisiertes sarcosinoxidase-praeparat.
ES2101936T3 (es) Estabilizadores oxamidicos.
NZ337924A (en) Site-specific drug delivery compounds comprising an anchoring moiety, a linking group and a drug
IT8919656A0 (it) Sistema convertitore cc cc ad elevate prestazioni dinamiche con controllo a divisione di tempo.
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
DE69000979D1 (de) Steuereinrichtung fuer brennstoffeinspritzpumpen.
IT9048574A0 (it) Iniettore per sostanze adesive munito di stantuffo.
DE69012950D1 (de) Antikrebsmittel.
DE69522923T2 (de) Sulfatierte Polyvinylalkoholpolymere zur Stabilisierung von Arzneimitteln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee